HLVX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HLVX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. HilleVax's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.12 Mil.
Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. HilleVax's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $48.08 Mil.
The historical data trend for HilleVax's Short-Term Debt & Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HilleVax Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Short-Term Debt & Capital Lease Obligation | 3.02 | 158.31 | 0.04 | 3.12 |
HilleVax Quarterly Data | |||||||||||||
Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Short-Term Debt & Capital Lease Obligation | Get a 7-Day Free Trial | 0.04 | 0.04 | 0.44 | 2.65 | 3.12 |
This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.
In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.
Be Aware
Stay away from companies that roll over the debt e.g. Bear Stearns
When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.
His favorite Wells Fargo has 57 cents short term debt for every dollar of long term
Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term
Thank you for viewing the detailed overview of HilleVax's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
Astrid Borkowski | officer: Chief Medical Officer | C/O HILLEVAX, INC., 75 STATE STREET, SUITE 100 - #9995, BOSTON MA 02109 |
Nanette Cocero | director | C/O HILLEVAX, INC., 75 STATE STREET, SUITE 100, BOSTON MA 02109 |
Shane Maltbie | officer: Chief Financial Officer | C/O AXCELLA HEALTH INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Frazier Life Sciences X, L.p. | 10 percent owner | 601 UNION STREET, SUITE 3200, TWO UNION SQUARE, SEATTLE WA 98101 |
Fhmls X, L.l.c. | 10 percent owner | 601 UNION STREET, SUITE 3200, TWO UNION SQUARE, SEATTLE WA 98101 |
Gary Dubin | director | C/O HILLEVAX, INC., 75 STATE STREET, SUITE 100 - #9995, BOSTON MA 02109 |
Jaime Sepulveda | director | C/O HILLEVAX INC., 75 STATE STREET 100 - #9995, BOSTON MA 02109 |
Takeda Vaccines, Inc. | 10 percent owner | 75 SIDNEY STREET, CAMBRIDGE MA 02139 |
Shelley Chu | director | ONE WINTHROP SQUARE, SUITE 400, BOSTON MA 02110 |
Susan Michele Silbermann | director | C/O LIANBIO, 103 CARNEGIE CENTER DRIVE, SUITE 215, PRINCETON NJ 08540 |
Fhmls X, L.p. | 10 percent owner | 601 UNION STREET, SUITE 3200, TWO UNION SQUARE, SEATTLE WA 98101 |
Julie L. Gerberding | director | 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
Aditya Kohli | director, officer: Chief Operating Officer | C/O PHATHOM PHARMACEUTICALS, INC., 2150 E. LAKE COOK ROAD, SUITE 800, BUFFALO GROVE IL 60089 |
David A Socks | officer: CFO & Chief Business Officer | C/O CADENCE PHARMACEUTICALS, INC., 12481 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130 |
Takeda Pharmaceutical Co Ltd | 10 percent owner | 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO M0 103-8668 |
From GuruFocus
By sperokesalga sperokesalga • 05-09-2023
By PurpleRose PurpleRose • 08-15-2022
By sperokesalga sperokesalga • 03-17-2023
By sperokesalga sperokesalga • 05-12-2023
By GuruFocusNews GuruFocusNews • 06-28-2022
By Value_Insider Value_Insider • 11-11-2022
By Value_Insider Value_Insider • 11-10-2022
By Marketwired • 09-25-2023
By GuruFocusNews GuruFocusNews • 05-03-2022
By GuruFocus Research • 11-21-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.